Switch to: References

Add citations

You must login to add citations.
  1. (1 other version)Ethical Quandaries in Gamete‐Embryo Cryopreservation Related to Oncofertility.Leslie Ayensu-Coker, Ellen Essig, Lesley L. Breech & Steven Lindheim - 2013 - Journal of Law, Medicine and Ethics 41 (3):711-719.
    While cancer rates continue to increase, therapy has dramatically decreased the mortality rates. The increased efficacy of current therapies may unfortunately have profound toxic effects on gamete function in both adolescent and reproductive age groups, with infertility as an expected consequence of cancer therapy. Significant progress in the advancement of fertility preservation therapies provides realistic options for future fertility in cancer survivors. However, a number of challenging issues need to be considered when presenting fertility preservation options. This overview highlights some (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical Guiding Principles of “Do No Harm” and the “Intention to Save Lives” in relation to Human Embryonic Stem Cell Research: Finding Common Ground between Religious Views and Principles of Medical Ethics.Mathana Amaris Fiona Sivaraman - 2019 - Asian Bioethics Review 11 (4):409-435.
    One of the goals of medicine is to improve well-being, in line with the principle of beneficence. Likewise, scientists claim that the goal of human embryonic stem cell research is to find treatments for diseases. In hESC research, stem cells are harvested from a 5-day-old embryo. Surplus embryos from infertility treatments or embryos created for the sole purpose of harvesting stem cells are used in the research, and in the process the embryos get destroyed. The use of human embryos for (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • (1 other version)Ethical Quandaries in Gamete-Embryo Cryopreservation Related to Oncofertility.Leslie Ayensu-Coker, Ellen Essig, Lesley L. Breech & Steven Lindheim - 2013 - Journal of Law, Medicine and Ethics 41 (3):711-719.
    Cancer rates in men and women of reproductive age have continued to increase in recent years; however, therapy has dramatically decreased the mortality rates. Since 1990, the prevalence of cancer survivors in young adults increased from 1 in 1,000 to 1 in 250 patients due to more aggressive therapies. Current therapies may have profound toxic effects on gamete function with infertility as an expected consequence of cancer therapy. Depending on the site and stage of cancer, age of the patient, and (...)
    Download  
     
    Export citation  
     
    Bookmark